Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
The study was backed by the Aufzien Family Center for the Prevention and Treatment of Parkinson's Disease at TAU. The paper ...
Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...
According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...
News Medical on MSN18h
New biomarker could help predict Parkinson’s disease progressionA team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...
This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...
Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...
Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...
About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback